Literature DB >> 3181380

Hepatitis B infections in the Arsi region of Ethiopia.

P Pasquini1, L Bisanti, L Soldo, P Palladino, C Rozera, E Frontini, A Miozzo, T M Di Gennaro, A Indi, S Conti.   

Abstract

In a sample of inhabitants of the Arsi region of Ethiopia prevalence of hepatitis B is around 80% in the age group 20-24. In addition to age, sex and size of family, exposure to tribal practices is a determinant of seropositivity in this group accounting for as much as 20% of the total burden of the infection. Waiting for a mass vaccination campaign, presently unrealistic in this area of the world, health education, as part of a comprehensive primary health care program, has to be considered as a potentially effective preventive tool.

Entities:  

Mesh:

Year:  1988        PMID: 3181380     DOI: 10.1007/bf00148915

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Current views on liver diseases in Ethiopia.

Authors:  E Tsega
Journal:  Ethiop Med J       Date:  1977-04

3.  Occurrence of hepatitis B surface antigen and its antibody in Ethiopian blood-donors.

Authors:  L Gebreselassie
Journal:  Ethiop Med J       Date:  1983-10

4.  Prevalence of hepatitis B markers in Italy.

Authors:  P Pasquini; H A Kahn; D Pileggi; A Panà; J Terzi; E Guzzanti
Journal:  Am J Epidemiol       Date:  1983-11       Impact factor: 4.897

5.  Detection of hepatitis B virus DNA in serum by a rapid filtration-hybridization assay.

Authors:  G Morace; K von der Helm; W Jilg; F Deinhardt
Journal:  J Virol Methods       Date:  1985-12       Impact factor: 2.014

6.  Hepatocellular carcinoma in Ethiopia. A prospective clinical study of 100 patients.

Authors:  E Tsega
Journal:  East Afr Med J       Date:  1977-05

7.  A study of hepatitis B antigen carriers among schoolchildren in Netanya, Israel.

Authors:  L Naggan; B Morag; S Bar-Shany; N Egoz; D Brachott
Journal:  Am J Epidemiol       Date:  1976-09       Impact factor: 4.897

8.  Hepatitis B in two Italian General Hospitals.

Authors:  P Pasquini; H A Kahn; D Pileggi; D Menichella; R Maddaluno; L Perroni; A Panà; E Guzzanti
Journal:  Boll Ist Sieroter Milan       Date:  1983-09-30

9.  Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.

Authors:  K Krogsgaard; P Wantzin; J Aldershvile; P Kryger; P Andersson; J O Nielsen
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

10.  Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen.

Authors:  T J Harrison; V Bal; E G Wheeler; T J Meacock; J F Harrison; A J Zuckerman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02
View more
  2 in total

1.  Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens.

Authors:  Moses Ndiritu; Karen D Cowgill; Amina Ismail; Salome Chiphatsi; Tatu Kamau; Gregory Fegan; Daniel R Feikin; Charles R J C Newton; J Anthony G Scott
Journal:  BMC Public Health       Date:  2006-05-17       Impact factor: 3.295

2.  Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia.

Authors:  Daniel Mekonnen; Solomon Gebre-Selassie; Surafel Fantaw; Andualem Hunegnaw; Adane Mihret
Journal:  Pan Afr Med J       Date:  2014-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.